Stereocontrolled dopamine receptor binding and subtype selectivity of clebopride analogues synthesized from aspartic acid

Bioorg Med Chem Lett. 2003 Oct 6;13(19):3293-6. doi: 10.1016/s0960-894x(03)00678-4.

Abstract

Employing the achiral 4-aminopiperidine derivative clebopride as a lead compound, chiral analogues were developed displaying dopamine receptor binding profiles that proved to be strongly dependent on the stereochemistry. Compared to the D1 receptor, the test compounds showed high selectivity for the D2-like subtypes including D2(long), D2(short), D3 and D4. The highest D4 and D3 affinities were observed for the cis-3-amino-4-methylpyrrolidines 3e and the enantiomer ent3e resulting in K(i) values of 0.23 and 1.8 nM, respectively. The benzamides of type 3 and 5 were synthesized in enantiopure form starting from (S)-aspartic acid and its unnatural optical antipode.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspartic Acid / chemistry
  • Aspartic Acid / metabolism*
  • Benzamides / chemical synthesis*
  • Benzamides / metabolism*
  • Protein Binding / physiology
  • Receptors, Dopamine / chemistry
  • Receptors, Dopamine / metabolism*
  • Stereoisomerism

Substances

  • Benzamides
  • Receptors, Dopamine
  • Aspartic Acid
  • clebopride